Search 

Link Health is a leading Chinese pharmaceutical company based in Southern China, focusing on the development of innovative drugs for the unmet medical needs.
Link Health has created a highly professional team with diverse expertise in drug development, medical affairs and regulatory affairs. Leveraging deep understanding of China market, favourable regulatory environment and strong network with global biopharmaceutical companies, Link Health is well positioned to bring innovative drugs to the market efficiently.
The company has established a fully owned subsidiary in Amsterdam, the Netherlands. The Dutch office focuses on collaborations with global pharma/biotech partners and research institutes.

Links global business. One hub for the Middle East

A public pharmaceutical company with over 30 years history, and mainly focuses on Respiratory, Digestive and Oncology areas.

Pharmaceutical company

An international enterprise dedicated to the innovation, ptoduce and selling of innovative drugs

Luye Pharma Group Co., Ltd. is a professional pharmaceutical enterprise built on a solid foundation of research and development and focusing on the largest and fastest growing therapeutic areas - central nervous system, oncology, cardiovascular system, and metabolism . The company was founded in 1994 and listed on the main board of the Hong Kong Stock Exchange in 2014 (02186.HK). The company has state-of-the-art production facilities located in Yantai, Nanjing, Beijing and Luzhou; as well as overseas branch offices in EU, United States, Singapore and Malaysia. The company has approximately 4,000 employees, including close to 300 R&D specialists and over 1,300 sales and marketing personnel. Luye Pharma is devoted to providing customers with high-quality innovative pharmaceutical products and professional services. The company currently sells approximately 30 products and over 80% of its total revenue is attributable to patent-protected products. Luye Pharma has an extensive sales & distribution network covering over 11,000 hospitals in 30 provinces, autonomous regions and municipalities in China, as well as exporting to many overseas countries and regions. Luye Pharma currently has 8 product candidates for overseas markets: one is preparing to submit NDA application; three are undergoing clinical trials in the US and one will start clinical trials in the US. soon.

In addition, Luye has its own biosimilar business (novel antibodies, prolia, xgeva, eylea, avastin, opdivo, trulicity, consentyx, zaltrap, CAR-T); Established in 2013, Boan Biotech is a fully-integrated biopharmaceutical company, specializing in the research & development, manufacturing and commercialization of therapeutic antibodies, which are mainly focused on key therapeutic areas such as oncology, diabetes and immunological diseases.

Luye Pharma Group, a member of Luye Life Sciences Group, is an international pharmaceutical company with a focus on targeting central nervous system (CNS), oncology and other therapeutic areas. Global R&D, global manufacturing, and the global sale of innovative medications are the company’s three main strategic priorities.

Our team at the Maryland Department of Commerce assists companies to establish operations and partnerships in one of the leading ecosystems for the life science industry in the United States.
- As one of the nation’s largest and fastest growing biotechnology clusters, Maryland is #1 in Ph.D. concentration in biological fields, employed doctoral scientists, and was recognized last year at the 4th best biotechnology cluster in the nation by Genetic Engineering and Biotechnology News.
- We have facilitated access to 74 Federal laboratories, including the National Institutes of Health, the National Institute for Standards and Technology, the Food and Drug Administration, and the Walter Reed Army Institute of Research.
- We can reach 80% of the U.S. pharmaceutical industry and four nearby international airports to enable efficient travel.
- Maryland’s Cost of Doing Business Index is 16%, 12%, and 10% lower than in Boston, New Jersey, and California, respectively, according to Moody’s Analytics Regional Financial Review. In our industry, that translates to a lower cost of operations and wet lab space.
- The cost of living in Maryland can be up to one-and-a-half times lower than in the metropolitan areas of New York, Boston, and San Francisco, according to the Council for Community and Economic Research.

MAVIE Technologies is an investment banking boutique in Chinese-Western healthcare transactions providing commercially-focused, end to end advice to maximize deal certainty and increase the intended value of transactions. Our team combines deal structuring sophistication and experience - whether it is private placement, secondary shares sale, joint-venture, licensing or M&A - with deep Chinese healthcare insights, strategic thinking and proprietary access. We add unique value in visualizing, negotiating and closing the deal.

A CAP, CLIA And AABB certified clinical lab specialized in genetic and molecular diagnosis